Marla C Dubinsky, MD
- PROFESSOR | Pediatrics, Gastroenterology
- PROFESSOR | Medicine, Gastroenterology
- Pediatric Gastroenterology
- Hospital Affiliation
- The Mount Sinai Hospital
Dr. Dubinsky received her medical degree from Queen’s University, Canada. She completed her Pediatric Residency at Alberta Children’s Hospital, Calgary, Canada and her Clinical Fellowship in Gastroenterology and Nutrition at Sainte-Justine Hospital at the University of Montreal, Canada. She then completed her Research Fellowship in Inflammatory Bowel Disease at Cedars-Sinai Medical Center in Los Angeles where she then served as the Director of the Pediatric Inflammatory Bowel Disease Center before coming to Mount Sinai as the Chief of the Division of Pediatric Gastroenterology at the Mount Sinai Kravis Children's Hospital. Her primary research focuses on the influence of genetics and immune responses on the variability in clinical presentations, treatment responses and prognosis of early-onset IBD. Her other interests include the impact of IBD on fertility and pregnancy. She has lectured widely both nationally and internationally and has published in 120 peer reviewed journals including Lancet, Gastroenterology, The Journal of Pediatric Gastroenterology and Nutrition, Inflammatory Bowel Diseases, and the American Journal of Gastroenterology. She also currently sits on the editorial boards of several leading journals.
Inflammatory Bowel Disease (IBD), Personalized Medicine, Pharmacogenomics
MD, Queen's University
Alberta Children's Hospital
Fellowship, Pediatric Gastroenterology
CHU Sainte-Justine (St. Justine Hospital)
International Organization for the Study of Inflammatory Bowel Disease
Abe and Claire Levine Chair in Pediatric Inflammatory Bowel Disease
Lectureship Award, University of Calgary
Corrine and Lenny Sands Clinical Investigator Award
Dr. Dubinsky's research interests include:
- Microbiome and genetics
- Pregnancy, preconception, and fertility
- Prognostic models
- Therapeutic drug monitoring
Dubinsky M. Have we changed the natural history of pediatric Crohn's disease with biologics? . Dig Dis. 2014; 32(4): 360-3.
Singh N, Rosenthal C, Melmed G, Mirocha J, Farrior S, Callejas S, Tripuraneni B, Rabizadeh S, Dubinsky M. Early Infliximab trough levels are associated with persistent remission in pediatric patients with inflammatory bowel disease. . Inflamm Bowel Dis 2014; 20: 1708-13.
Bradford K, Melmed G, Fleshner P, Silverman N, Dubinsky M. Significant Variation in Recommendation of Care for Women of Reproductive Age with Ulcerative Colitis Postileal Pouch-Anal Anastomosis.. Dig Dis Sci. 2014 Feb 19;.
Vahabnezhad E, Rabizadeh S, Dubinsky M. A 10-Year, Single Tertiary Care Center Experience on the Durability of Infliximab in Pediatric Inflammatory Bowel Disease. . Inflamm Bowel Dis. 2014 Feb 18;.
Dulai P, Thompson K, Blunt H, Dubinsky M, Siegel C. Risks of Serious Infection or Lymphoma with Anti-Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: a Systematic Review.. Clin Gastroenterol Hepatol. 2014 Jan 22;.
Dulai P, Siegel C, Dubinsky M. Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease.. Inflamm Bowel Dis. 2013; 19: 2927-36.
Dubinsky M, Kugathasan S, Kwon S, Haritunians T, Wrobel I, Wahbeh G, Quiros A, Bahar R, Silber G, Farrior S, Stephens M, Teleten N, Panikkath D, Ippoliti A, Vasiliauskas E, Fleshner P, Williams C, Landers C, Rotter J, Targan S, Taylor K, McGovern D. Multi-dimensional prognostic risk assessment identifies association between IL12B variation and surgery in Crohn’s disease.. Inflamm Bowel Dis 2013; 0: 1-9.
Mahadevan U, Wolf D, Dubinsky M, Cortot A, Lee S, Siegel C, Ullman T, Glover S, Valentine J, Rubin D, Miller J, Abreu M. Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients with Inflammatory Bowel Disease. . Clin Gastroenterol Hepatol. 2013; 11: 286-92.
Siegel C, Siegel L, Hyams J, Kugathasan S, Markowitz J, Rosh J, Leleiko N, Mack D, Crandall W, Evans J, Keljo D, Otley A, Oliva-Hemker M, Farrior S, Langton C, Wrobel I, Wahbeh G, Quiros J, Silber G, Bahar R, Sands B, Dubinsky M. A Real-Time tool to display the predicted disease course and treatment response for children with Crohn's disease. . Inflammatory Bowel Diseases 2011; 17: 30-8.
Dubinsky M, Mei L, Friedman M, Dhere T, Haritunians T, Hakonarson H, Kim C, Glessner J, Targan S, McGovern D, Taylor K, Rotter J. Genome Wide association (GWA) predictors of anti-TNF therapeutic responsiveness in pediatric Inflammatory bowel disease. . Inflammatory Bowel Diseases 2010; 16: 1357-66.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Dubinsky did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.